title: Cyclic dipeptides from rhabditid entomopathogenic nematode-associated Bacillus cereus have antimicrobial activities.
abstract: The cell free culture filtrate of Bacillus cereus associated with an entomopathogenic nematode, Rhabditis (Oscheius) sp. exhibited strong antimicrobial activity. The ethyl acetate extract of the bacterial culture filtrate was purified by silica gel column chromatography to obtain four bioactive compounds. The structure and absolute stereochemistry of these compounds were determined based on extensive spectroscopic analyses (FABMS, (1)H NMR, (13)C NMR, (1)H-(1)H COSY, (1)H-(13)C HMBC) and Marfey's method. The compounds were identified as cyclic dipeptides (CDPs): cyclo(L-Pro-L-Trp), cyclo(L-Leu-L-Val), cyclo(D-Pro-D-Met), and cyclo(D-Pro-D-Phe), respectively. Compounds recorded significant antibacterial activity against all the test bacteria (Staphylococcus epidermidis, Staphylococcus aureus, Klebsiella pneumoniae, Escherichia coli, Pseudomonas aeruginosa and methicillin-resistant S. aureus) except cyclo(L-Leu-L-Val). Cyclo(L-Leu-L-Val) recorded activity only against Gram positive bacteria. Best antibacterial activity was recorded by cyclo(L-Pro-L-Trp) against S. aureus (4 μg/ml). The four compounds were active against all the five fungi tested (Trichophyton rubrum, Aspergillus flavus, Candida albicans, Candida tropicalis and Cryptococcus neoformans) and the activity was compared with amphotericin B, the standard fungicide. The highest activity of 1 μg/ml by cyclo(L-Pro-L-Trp) was recorded against T. rubrum, a human pathogen responsible for causing athlete's foot, jock itch, and ringworm. The activity of cyclo(L-Pro-L-Trp) against T. rubrum, C. neoformans and C. albicans were better than amphotericin B, the standard antifungal agent. To our knowledge, this is the first report of antifungal activity of CDPs against the human pathogenic fungi T. rubrum and C. neoformans. The four CDPs are nontoxic to healthy human cell line up to 200 μg/ml. We conclude that the bacterium associated with entomopathogenic nematode is promising sources of natural antimicrobial secondary metabolites, which may receive greater benefit as potential sources of new drugs in the pharmaceutical industry.
authors: Division of Crop Protection/Division of Crop Utilization, Central Tuber Crops Research Institute, Sreekariyam, Thiruvananthapuram, 695017, India.
authors: S
authors: S
authors: Nishanth Kumar
authors: Vishnu Sukumari
authors: VS
authors: Nath
authors: R
authors: R
authors: Pratap Chandran
authors: Bala
authors: B
authors: Nambisan
mesh_terms: D000818:Animals; D000890:Anti-Infective Agents / Q000302:isolation & purification / Q000494:pharmacology*; D001409:Bacillus cereus / Q000737:chemistry* / Q000302:isolation & purification; D001419:Bacteria / Q000187:drug effects*; D004151:Dipeptides / Q000302:isolation & purification / Q000494:pharmacology*; D005658:Fungi / Q000187:drug effects*; D008826:Microbial Sensitivity Tests; D010456:Peptides, Cyclic / Q000302:isolation & purification / Q000494:pharmacology*; D017172:Rhabditoidea / Q000382:microbiology*
chemical_list: D000890:Anti-Infective Agents; D004151:Dipeptides; D010456:Peptides, Cyclic
references: Biofouling. 2006;22(3-4):201-8
references: 17290864
references: J Nat Prod. 1991 May-Jun;54(3):774-84
references: 1955880
references: Int J Antimicrob Agents. 2004 Nov;24(5):423-7
references: 15519471
references: Can J Microbiol. 1997 Aug;43(8):770-3
references: 9304787
references: Peptides. 2008 Aug;29(8):1305-11
references: 18436344
references: Appl Environ Microbiol. 2002 Sep;68(9):4322-7
references: 12200282
references: J Nat Prod. 2003 Oct;66(10):1299-301
references: 14575426
references: Mol Microbiol. 1999 Sep;33(6):1254-66
references: 10510239
references: J Nat Prod. 1994 Jun;57(6):829-32
references: 7931369
references: J Nat Prod. 1991 May-Jun;54(3):785-95
references: 1955881
references: Curr Microbiol. 2002 Oct;45(4):250-4
references: 12192521
references: Pharmazie. 1993 Apr;48(4):308-9
references: 8321884
references: Anticancer Drugs. 2006 Jan;17(1):25-31
references: 16317287
references: J Appl Microbiol. 2009 Sep;107(3):746-59
references: 19320949
references: Pharmazie. 1999 Oct;54(10):772-5
references: 10563376
references: Lett Appl Microbiol. 1998 Feb;26(2):118-22
references: 9569693
references: J Chem Ecol. 1981 May;7(3):589-97
references: 24420598
references: J Med Chem. 2004 Nov 4;47(23):5713-20
references: 15509170
references: Int J Syst Evol Microbiol. 2010 Aug;60(Pt 8):1921-1937
references: 19783607
references: J Gen Microbiol. 1982 Dec;128(12):3061-5
references: 7183749
references: J Nat Prod. 2008 Jun;71(6):1074-7
references: 18491867
references: FEMS Microbiol Lett. 2004 Oct 15;239(2):241-8
references: 15476972
references: Peptides. 1995;16(1):151-64
references: 7716068
references: Exp Biol Med (Maywood). 2003 Dec;228(11):1338-45
references: 14681549
references: Appl Environ Microbiol. 1995 Dec;61(12):4329-33
references: 8534100
references: J Antibiot (Tokyo). 2009 Jun;62(6):295-302
references: 19373275
references: Biomol Eng. 2003 Jul;20(4-6):311-6
references: 12919814
references: Evid Based Complement Alternat Med. 2011;2011:393752
references: 21785621
references: J Biol Chem. 2003 Jul 11;278(28):25490-8
references: 12714587
references: Annu Rev Microbiol. 1997;51:47-72
references: 9343343
references: J Nat Prod. 1996 Mar;59(3):293-6
references: 8882433
references: Microbiol Rev. 1996 Mar;60(1):21-43
references: 8852894